FilingReader Intelligence
Jiangsu Nhwa Pharmaceutical unlocks restricted shares after profit growth
July 29, 2025 at 05:25 PM UTC•By FilingReader AI
Jiangsu Nhwa Pharmaceutical unlocked 22.64 million restricted shares on August 14, 2025, representing 0.22% of total share capital. The release followed achievement of performance targets including 2024 net profit growth exceeding 15%.
The company reported 2025 semi-annual revenue of 3.01 billion yuan and net profit of 700.5 million yuan.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
Half-year report financial statementsJuly 29, 2025 at 08:00 AM UTC
2025 semi-annual reportJuly 29, 2025 at 08:00 AM UTC
Announcement on the fulfillment of unlock conditions for the first restricted period of restricted shares granted under the 2024 restricted stock incentive planJuly 29, 2025 at 08:00 AM UTC
Summary table of semi-annual non-operating fund occupation and other related party fund transactionsJuly 29, 2025 at 08:00 AM UTC
2025 semi-annual report summaryJuly 29, 2025 at 08:00 AM UTC
SZSE:002262•Shenzhen Stock Exchange
News Alerts
Get instant email alerts when Jiangsu Nhwa Pharmaceutical publishes news
Free account required • Unsubscribe anytime